Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]
News [5245]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Combined ibrutinib and venetoclax in patients with treatment-naïve high-risk CLL ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Phase II trial of nivolumab combined with ibrutinib for patients with Richter...
Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA
Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation ( Dr Nitin Jain - MD Anderson Cancer Centre, Houston, USA )
17 Dec 2018
Maintenance therapy with the oral PI ixazomib significantly prolongs PFS...
Dr Francesca Gay - University of Torino, Torino, Italy
Maintenance therapy with the oral PI ixazomib significantly prolongs PFS following ASCT in multiple myeloma ( Dr Francesca Gay - University of Torino, Torino, Italy )
13 Dec 2018
Role of chemotherapy in the treatment of metastatic breast cancer patients
Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani
Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )
10 Dec 2018
The combined analysis of carfilzomib trials for multiple myeloma
Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain
The combined analysis of carfilzomib trials for multiple myeloma ( Prof Maria-Victoria Mateos - University of Salamanca, Salamanca, Spain )
7 Dec 2018
Matched targeted therapy for paediatric patients with relapsed, refractory or...
Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA
Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias ( Dr Yana Pikman - Dana Farber Cancer Institute, Boston, USA )
6 Dec 2018
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline...
Dr Lorenz Trümper - Georg August University, Göttingen, Germany
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas ( Dr Lorenz Trümper - Georg August University, Göttingen, Germany )
6 Dec 2018
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed...
Prof Marion Subklewe - University of Munich, Munich, Germany
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML ( Prof Marion Subklewe - University of Munich, Munich, Germany )
6 Dec 2018
Patient treatment preferences in relapsed/refractory multiple myeloma
Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos
Patient treatment preferences in relapsed/refractory multiple myeloma ( Dr Joseph Mikhael, Prof James Chim and Prof Evangelos Terpos )
3 Dec 2018
Landscape change with oral proteasome maintenance in multiple myeloma patients
Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar...
Landscape change with oral proteasome maintenance in multiple myeloma patients ( Prof Maria-Victoria Mateos, Prof Wee Joo Chng, Prof Meral Beksac and Dr Sagar Lonial )
3 Dec 2018
The importance of NF-kB pathway in myeloma
Dr Nizar Bahlis - University of Calgary, Calgary, Canada
The importance of NF-kB pathway in myeloma ( Dr Nizar Bahlis - University of Calgary, Calgary, Canada )
3 Dec 2018
Multiple myeloma highlights and more from ASH 2018
Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France
Multiple myeloma highlights and more from ASH 2018 ( Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France )
3 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation